PTI is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Strategic Finance in (Bio)Pharma for the Non-Specialist

9 - 10 November 2020

Radisson Blu Edwardian Kenilworth, London

Finance plays a crucial role in organisations of all sizes whether it be measuring the profit and loss of a product or division, making investment decisions or determining the health of your organisation now and in the future.

As a manager it is important that you have a fundamental understanding of financial management so you can interpret financial data, challenge your accounting team and make business critical decisions.

This two-day course has been specifically designed to give you a comprehensive understanding of financial management within the (bio) pharmaceutical industry. Over two days you will examine the key financial statements, discuss ratio analysis, examine costs, review budgeting and discuss project appraisal tools. Once completed you will have the skills and knowledge to understand financial management within the (bio)pharmaceutical industry.

  • Demystify accounting terms and concepts
  • Build financial knowledge to challenge, contribute and discuss financial management and decisions. 
  • Interpret and critically analyse financial results more effectively and efficiently
  • Select and use appropriate financial decision-making methods
  • Understand the crucial aspects of an organisation's working capital
  • Understand and work with the concepts of time value of money with a strong focus on Internal Rate of Return (IRR) and Net Present Value (NPV)
  • Learn how to interpret a cash flow statement to determine the reasons for a company’s positive or negative cash flow
  • Learn to apply project appraisal techniques to support you in decision making

Andre Lanser ACA

Andre is a consulting trainer as well as a corporate finance practitioner. He has delivered courses for banks around the world in the areas of Credit, Corporate Finance, Valuation and Financial Modelling.

Andre qualified as a Chartered Accountant, completing articles with PricewaterhouseCoopers. He started his career with a subsidiary of Commercial Union, involved in the steel manufacturing industry. His experience ranged from systems implementation, credit assessment of the highly risky construction industry customers, heading up the finance functions to successfully turning the business around and then selling the company through a trade sale.  He later joined Commercial Union in the investment back-office function, reengineering the investment back office and later headed-up a team who implemented a new investment management system for both the back office and the front office. 

His career then spanned over 12 years in the Venture Capital and Private Equity arena, where he has gained a vast amount of experience in the corporate analysis and valuation field.

He is a specialist in developing and training finance related courses, including corporate credit related topics, credit analysis and cash flow analysis with a special focus on the banking sector, derivatives, and financial modelling courses. His training experience spans a period of more than 15 years.

This course is aimed at non-financial managers such as middle/senior management who are responsible for budgets, investment decisions and company strategy and who would benefit from having a deeper understanding of finance.

We're looking forward to welcoming our attendees and expert course leaders at Strategic Finance in (Bio)Pharma for the Non-Specialist in London in June.

Our number one priority is the safety of our delegates and colleagues, and there are always measures in place at our venues to safeguard your health and safety. There are extra measures in place for 2020 in light of developments with COVID-19.

Book with total confidence – click here to be fully assured on how your booking rights are protected.